Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the clinical efficacy of intravitreal injections of Ranibizumab
(Lucentis) together with chemotherapy in the treatment of Retinoblastoma as compared to
chemotherapy alone.